Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023-Reference-Cited by-同舟云学术

Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023

Published:2024-04 Issue:10 Volume:24 Page:843-849
ISSN:1568-0266
Container-title:Current Topics in Medicinal Chemistry
language:en
Short-container-title:CTMC

Author:

Ali Saghir¹,Bolinger Andrew A.¹,Zhou Jia²

Affiliation:

1. Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, 77555, United States

2. Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, 77555, United States

Abstract

Abstract: Fluorine continues to show its potential applications in drug discovery and development, as reflected by twelve drugs being fluorinated out of the fifty-five approved by the FDA in 2023. This concise review highlights the discovery of each of these fluorine-containing drugs in the past year, including its brand name, date of approval, composition, sponsors, indication, and mechanism of action. The relevant future trend is also briefly discussed.

Funder

National Institutes of Health

Publisher

Bentham Science Publishers Ltd.

Reference45 articles.

1. Roesky H.W.; Sharpless K.B.; Efficient Preparations of Fluorine Compounds 2012

2. Müller K.; Faeh C.; Diederich F.; Fluorine in pharmaceuticals: Looking beyond intuition. Science 2007,317(5846),1881-1886

3. Godhaviya P.K.; Studies of Fluorine: History, Application, water Fluoridation, Organo Fluorine 2015

4. Groult H.; Leroux F.; Tressaud A.; Modern Synthesis Processes and Reactivity of Fluorinated Compounds: Progress in Fluorine Science 2016

5. Haufe G.; Leroux F.; Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals: Progress in Fluorine Science Series 2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deoxyfluorination of Ketones with Sulfur Tetrafluoride (SF₄) and Dialkylamines in Continuous Flow Mode;Organic Process Research & Development;2024-07-08

2. Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists;Journal of Medicinal Chemistry;2024-05-24